Thank you.
One group we frequently hear from in regard to the cost of medicines are advocates for those with rare diseases whose drugs carry a higher price if they are not widely used.
As you are aware, the government is also considering a rare diseases strategy. Can you make any recommendations for this strategy? Can you explain how these new guidelines will bring down these prices and help people presently living with rare diseases?